<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(10)</volume><submitter>Murrone A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Malignant pleural mesothelioma (MPM) is an aggressive disease, with few available treatment options. Identification of novel prognostic and predictive biomarkers is a priority. In MPM patients, BRCA-associated protein 1 (BAP1) alterations are detected in about 60% of cases and miR-31 seems to be involved in BAP1 regulation at post-transcriptional level. The aim of this study was to evaluate the interaction between BAP1 and miR-31 in MPM and their prognostic role in MPM.&lt;h4>Methods&lt;/h4>The expression of BAP1 and miR-31 was analyzed in tissues of 55 MPM patients treated with first-line chemotherapy. Overall survival (OS) and progression-free survival (PFS) were assessed by Kaplan-Meier method and Log-rank test was used to investigate differences among subgroups. Multivaria</pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>5741-5751</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8575852</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.</pubmed_title><pmcid>PMC8575852</pmcid><pubmed_authors>Rinaldi S</pubmed_authors><pubmed_authors>Giampieri R</pubmed_authors><pubmed_authors>Murrone A</pubmed_authors><pubmed_authors>Bianchi F</pubmed_authors><pubmed_authors>Tomasetti M</pubmed_authors><pubmed_authors>Fiordoliva I</pubmed_authors><pubmed_authors>Rubini C</pubmed_authors><pubmed_authors>Berardi R</pubmed_authors><pubmed_authors>Copparoni C</pubmed_authors><pubmed_authors>Monaco F</pubmed_authors><pubmed_authors>Cimadamore A</pubmed_authors><pubmed_authors>Santarelli L</pubmed_authors><pubmed_authors>Cognigni V</pubmed_authors><pubmed_authors>Amati M</pubmed_authors><pubmed_authors>Pecci F</pubmed_authors><pubmed_authors>Cantini L</pubmed_authors><pubmed_authors>Barbisan F</pubmed_authors></additional><is_claimable>false</is_claimable><name>BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.</name><description>&lt;h4>Background&lt;/h4>Malignant pleural mesothelioma (MPM) is an aggressive disease, with few available treatment options. Identification of novel prognostic and predictive biomarkers is a priority. In MPM patients, BRCA-associated protein 1 (BAP1) alterations are detected in about 60% of cases and miR-31 seems to be involved in BAP1 regulation at post-transcriptional level. The aim of this study was to evaluate the interaction between BAP1 and miR-31 in MPM and their prognostic role in MPM.&lt;h4>Methods&lt;/h4>The expression of BAP1 and miR-31 was analyzed in tissues of 55 MPM patients treated with first-line chemotherapy. Overall survival (OS) and progression-free survival (PFS) were assessed by Kaplan-Meier method and Log-rank test was used to investigate differences among subgroups. Multivaria</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T13:57:42.778Z</modification><creation>2025-04-04T13:57:42.778Z</creation></dates><accession>S-EPMC8575852</accession><cross_references><pubmed>34795923</pubmed><doi>10.21037/jtd-21-555</doi></cross_references></HashMap>